Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CBLL
CBLL logo

CBLL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ceribell Inc (CBLL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.910
1 Day change
0.84%
52 Week Range
24.330
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ceribell Inc (CBLL) is not an optimal buy for a beginner, long-term investor at this moment. While the company has shown strong revenue growth and improving financials, the lack of significant positive trading signals, neutral sentiment from hedge funds and insiders, and no recent news catalysts suggest limited immediate upside. Additionally, the technical indicators are mixed, and the stock is trading near a key support level, indicating potential price consolidation. It would be prudent to monitor the stock for a better entry point or stronger signals.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 39.05, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 18.327, and resistance is at 19.824. The stock is trading close to its support level, suggesting limited immediate upside.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • Revenue increased by 33.72% YoY in Q4 2025, and analysts maintain a Buy rating with a price target of $28, indicating long-term growth potential.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from hedge funds or insiders. Gross margin slightly declined YoY, and the stock is down 1.97% in the last session.

Financial Performance

In Q4 2025, revenue grew by 33.72% YoY to $24.78M. Net income improved by 7.56% YoY but remains negative at -$13.53M. EPS increased to -0.36, up 2.86% YoY. Gross margin slightly declined to 87.33%, down 0.32% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Canaccord lowered the price target from $30 to $28 but maintained a Buy rating, citing a solid Q4 beat and conservative guidance with multiple growth drivers ahead.

Wall Street analysts forecast CBLL stock price to rise
4 Analyst Rating
Wall Street analysts forecast CBLL stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 17.760
sliders
Low
29
Averages
29.67
High
30
Current: 17.760
sliders
Low
29
Averages
29.67
High
30
Canaccord
Buy
downgrade
$30 -> $28
AI Analysis
2026-02-25
Reason
Canaccord
Price Target
$30 -> $28
AI Analysis
2026-02-25
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Ceribell to $28 from $30 and keeps a Buy rating on the shares. The firm said they reported a solid beat for Q4 and gave conservative guidance as the company has multiple drivers upcoming.
Canaccord
Buy
maintain
$29 -> $30
2025-12-17
Reason
Canaccord
Price Target
$29 -> $30
2025-12-17
maintain
Buy
Reason
Canaccord raised the firm's price target on Ceribell to $30 from $29 and keeps a Buy rating on the shares. The firm said they continue to be bullish on the Med-Tech sector heading into 2026. They point to strong underlying demand from an aging population, a focus on acute healthcare needs, the healthy pace of M&A, and a market that is receptive to IPOs as the foundation for our belief in our positive outlook in the upcoming year.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CBLL
Unlock Now

People Also Watch